NCT05267587View on ClinicalTrials.gov

Preop fSRS for Resectable Brain Metastases

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 11, 2022

Primary Completion Date

May 29, 2025

Study Completion Date

August 21, 2026

Conditions
Brain MetastasesBrain Lesion
Interventions
RADIATION

Hypofractionated Stereotactic Radiosurgery

Participants will be given hypofractionated stereotactic radiosurgery (fSRS) in 9 Gray Units (Gy) per fraction x 3 consecutive daily fractions (27 Gy total) to the index metastasis that will be resected.

Trial Locations (1)

33612

Moffitt Cancer Center, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER